Pharmaceuticals Headlines from PR Newswire

< Go Back

FDA approves Jardiance® (empagliflozin) tablets for adults with type 2 diabetes
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire
Pharmaceuticals Learning the Language of the New Healthcare Landscape
Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit
XBiotech Enrolls First Patient in Phase III European Registration Study Using Xilonix™ for Treatment of Colorectal Cancer
VanDeMark Chemical Inc. Acquires Framochem
RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation
60+ Healthcare Professionals Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score
Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction
Wound Care Market Worth $18.3 Billion by 2019
AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program
Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014
FDA Approves Boehringer Ingelheim's Striverdi® Respimat® (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Neuland Labs Reports First Quarter Fiscal Year 2015 Financial Results
Soligenix Receives Additional NIAID Funding to Advance Development of OrbeShield™ in GI ARS
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results
PCMA: Medicare Part D 2015 Premiums Remain Flat
Sorrento Announces the Unexpected Death of its Chief Business Officer
Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014
Alexza Provides Pipeline Update
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Cepheid to Webcast Upcoming Financial Presentations
Pharmacyclics Reports Second Quarter 2014 Results
Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Denmark For The Treatment Of Chronic Diabetic Macular Edema
Xencor Reports Second Quarter 2014 Financial Results
Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs
Cancer Network Highlights Methods Oncologists Can Use to Improve Communication English
Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed
Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement
Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up
Touro University California Garners Grant From Long Foundation
First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development
Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders
Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies
LabStyle Innovations Announces the Initial Launch of the Dario™ Diabetes Management Solution for Android Devices
The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene
TB Alliance Names Elana Robertson Senior Vice President, Market Access
TB Alliance Appoints Willo Brock Senior Vice President, External Affairs
Meditech Leads Global Clinical DSS Market (Clinical Decision Support System) Says a Research Report With 2018 Forecasts and Analysis
The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications
Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO.
ChromaDex Signs Material Transfer Agreement With Prominent Australian Research Institute for NIAGEN™ Research
CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC
Sanofi: Solid Sales and Business EPS Growth at CER
Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China

< Prev Next >
PR Newswire - United Business Media